Podcast 94: What does a new meta-analysis tell us about statins and primary prevention?

A meta-analysis of 11 studies encompassing more than 60,000 subjects finds that statins don’t lower all-cause mortality in people without cardiovascular disease. One editorialist calls the study, just published in the Archives of Internal Medicine, “the cleanest and most complete meta-analysis of pharmacological lipid lowering for primary prevention.” One of the study’s principal authors, Kausik K. Ray, talked with us from London. I think you’ll find that listening in is worth your time. Interview-related links: Physician’s First Watch coverage of the Archives‘s statin papers Ray et al.‘s meta-analysis News-related links: Starting dialysis early doesn’t improve mortality Digoxin’s dangers in dialysis Rosiglitazone’s bad week Tight glucose control in diabetes brings some benefits, but at the cost of “imprudent” risks PSA testing for prostate cancer lowers mortality, but mostly in low-screening regions The post Podcast 94: What does a new meta-analysis tell us about statins and primary prevention? first appeared on Clinical Conversations.